Get the Stockscreener App
6.05
2.02%
0.12
After Hours:
6.15
0.10
+1.65%
Optimizerx Corp stock is traded at $6.05, with a volume of 318.63K.
It is up +2.02% in the last 24 hours and down -5.47% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
See More
Previous Close:
$5.93
Open:
$5.96
24h Volume:
318.63K
Relative Volume:
0.71
Market Cap:
$113.51M
Revenue:
$109.43M
Net Income/Loss:
$5.13M
P/E Ratio:
23.22
EPS:
0.2606
Net Cash Flow:
$18.91M
1W Performance:
-9.02%
1M Performance:
-5.47%
6M Performance:
-69.60%
1Y Performance:
-27.37%
1-Day Range:
$5.93
$6.20
1-Week Range:
$5.77
$7.22
52-Week Range:
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.05 | 115.01M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? - qz.com
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Whats the profit margin of OptimizeRx Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
OptimizeRx Corp. Receives Favorable Valuation Adjustment Amidst Profit Growth and High Institutional Confidence - Markets Mojo
OptimizeRx Adds Microsoft Health Leader to Board - TipRanks
OptimizeRx adds Microsoft Health exec to board of directors - Investing.com
Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan
OptimizeRx Appoints Microsoft Health & Life Sciences COO to Board - National Today
OptimizeRx Appoints Mary Varghese Presti to Board of Directors - Bitget
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - qz.com
Best Value Stocks to Buy for March 16th - Eastern Progress
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
New Top-Rated Stocks to Buy for April 1st - Bitget
OPRX Should I Buy - Intellectia AI
OptimizeRx (NASDAQ: OPRX) switches auditors from UHY LLP to Grant Thornton - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Vanguard disaggregates holdings; OPRX parent reports 0 shares (OPRX) - Stock Titan
OPRX Technical Analysis & ETF Price Forecast - Intellectia AI
OptimizeRx (OPRX) Jumps 5.9%: Does the Stock Have More Room to Grow? - Bitget
Earnings call transcript: OptimizeRx Q4 2025 earnings beat forecasts, stock dips - Investing.com Australia
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock? - finance.yahoo.com
Best Value Stocks to Buy for March 24th - sharewise.com
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN
OPRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat
Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN
OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN
OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):